Yoshihiro Kawaoka is studying COVID-19 at his posts at UW–Madison and the University of Tokyo. When Yoshihiro Kawaoka first came to the United States in the summer of 1983 to work on influenza viruses, the man who became his American mentor, Dr. Robert Webster of...
As Americans begin pulling up their sleeves for an annual flu vaccine, researchers at the University of Wisconsin–Madison have provided new insights into an alternative vaccine approach that provides broader protection against seasonal influenza....
A national research initiative announced today will place the University of Wisconsin-Madison at the forefront of a revolution in imaging fostered by cryo-electron microscopy and cryo-electron tomography — technologies that can illuminate life at the atomic scale....
The race to develop a vaccine for the novel coronavirus that causes COVID-19 is happening with unprecedented speed, and will represent the largest global vaccination effort since the fight against polio nearly 70 years ago....
UW-Madison’s College of Engineering received its largest donation in the college’s history that will start a new scholarship program, help expand the undergraduate student body and create several professorships to keep top talent in Madison....
While economic uncertainty and the changes to daily life caused by the global pandemic have created countless challenges for business owners across many sectors, startup companies founded by UW–Madison innovators have managed to demonstrate resilience....
UW Health and the University of Wisconsin School of Medicine and Public Health (SMPH) are among the first sites in the country to study whether an investigational vaccine developed by the pharmaceutical company AstraZeneca can prevent COVID-19, the disease caused by the new coronavirus SARS-CoV-2....
PROGRAM GOAL: The goal of the Wisconsin Investment Pilot (WIP) Program is to support technology-based startup and emerging growth companies in the state of Wisconsin. This program was initiated by the Entrepreneurship and Innovation Committee to support early-stage companies trying to raise additional or bridge capital...
Waisman Biomanufacturing at the University of Wisconsin–Madison will begin manufacturing a new drug to treat and prevent COVID-19, developed by California-based biotech company GigaGen....
It’s like searching for a needle in a haystack. Except the haystack is human excrement. The needle, a tiny fragment of the tiny genetic material of a tiny virus that has, since December 2019, had a massive impact on the world....
The University of Wisconsin–Madison College of Agricultural and Life Sciences (CALS) recently selected seven projects for funding through the Dairy Innovation Hub initiative. The one-year grants will fund promising work in the Hub’s four priority areas: stewarding land and water resources; enriching human health and...
Applications are being accepted now from young companies that want to tell their stories to investors at our annual Wisconsin Early Stage Symposium #ESSWI, to be held Nov. 9-11 on a virtual platform....
Why is it that some COVID-19 patients become extremely ill and die, while others experience only mild symptoms? The molecular underpinnings of COVID-19 are the subject of a recent collaboration between the Morgridge Institute for Research, the University of Wisconsin-Madison, and Albany Medical College. ...
Many U.S. policymakers seem concerned about reopening bars, restaurants and health clubs closed during the COVID-19 pandemic. They should be at least as worried about restarting America’s education engine, which will best serve the economy – and young people – over time. The differences between how...
[caption id="attachment_170906" align="alignright" width="500"] UW-Madison Chancellor Rebecca Blank[/caption] We’re on the cusp of what is sure to be one of the most unusual fall semesters in our university’s history. If you’re a student, I want to take a moment to welcome you back. If you’re an employee,...
The University of Wisconsin-Madison is now publicly tracking COVID-19 test results daily on a new website, as it begins welcoming students back to campus and prepares for in-person instruction....
A Crisis Innovator is a company that is addressing the virus head-on, whether it be through developing a vaccine, designing Covid test kits or helping retailers abide by social distancing guidelines. At their core, Crisis Innovators are working to keep people safe amid the virus,...
Coronavirus disease 2019 (COVID-19) is a respiratory illness that can spread from person to person. This series of guides can help you avoid infection, recognize symptoms and care for others. At the end, take a quiz to see if you can separate virus facts from...
“We’re in the middle of a public health crisis and we’re trying to build the airplane while free falling,” said Dr. Jonathan Temte, associate dean of the UW School of Medicine and Public Health, who is on a federal work group and a state committee...
“Now more than ever, dairy businesses must work quickly to adapt to changes in consumer demands and market opportunities. We are pleased to be able to put USDA funds to work, building upon the tremendous interest in the first initiative, to help dairy farmers and...